Please use this identifier to cite or link to this item: http://sgc.anlis.gob.ar/handle/123456789/2057
DC FieldValueLanguage
dc.contributor.authorAbbate, Eduardoes
dc.contributor.authorVescovo, Marisaes
dc.contributor.authorNatiello, Marcelaes
dc.contributor.authorCufré, Mónicaes
dc.contributor.authorGarcía, Anaes
dc.contributor.authorGonzalez Montaner, Pabloes
dc.contributor.authorAmbroggi, Martaes
dc.contributor.authorRitacco, Vivianaes
dc.contributor.authorvan Soolingen, Dickes
dc.date.accessioned2021-01-05T21:26:36Z-
dc.date.available2021-01-05T21:26:36Z-
dc.date.issued2012-02-
dc.identifier.issn1460-2091-
dc.identifier.urihttp://sgc.anlis.gob.ar/handle/123456789/2057-
dc.descriptionFil: Abbate, Eduardo. Instituto de Tisioneumonología ‘Prof. Dr. Raúl Vaccarezza’, Universidad de Buenos Aires; Argentina.es
dc.descriptionFil: Vescovo, Marisa. Instituto de Tisioneumonología ‘Prof. Dr. Raúl Vaccarezza’, Universidad de Buenos Aires; Argentina.es
dc.descriptionFil: Natiello, Marcela. Instituto de Tisioneumonología ‘Prof. Dr. Raúl Vaccarezza’, Universidad de Buenos Aires; Argentina.es
dc.descriptionFil: Cufré, Mónica. Instituto de Tisioneumonología ‘Prof. Dr. Raúl Vaccarezza’, Universidad de Buenos Aires; Argentina.es
dc.descriptionFil: García, Ana. Instituto de Tisioneumonología ‘Prof. Dr. Raúl Vaccarezza’, Universidad de Buenos Aires; Argentina.es
dc.descriptionFil: Gonzalez Montaner, Pablo. Instituto de Tisioneumonología ‘Prof. Dr. Raúl Vaccarezza’, Universidad de Buenos Aires; Argentina.es
dc.descriptionFil: Ambroggi, Marta. Instituto de Tisioneumonología ‘Prof. Dr. Raúl Vaccarezza’, Universidad de Buenos Aires; Argentina.es
dc.descriptionFil: Ritacco, Viviana. ANLIS Dr.C.G.Malbrán. Instituto Nacional de Enfermedades Infecciosas; Argentina.es
dc.descriptionFil: van Soolingen, Dick. National Tuberculosis Reference Laboratory, National Institute for Public Health and the Environment, Bilthoven; Países Bajos.es
dc.description.abstractCurrent drug choices to treat extensively drug-resistant (XDR) tuberculosis (TB) are scarce; therefore, information on the safety, tolerability and efficacy of alternative regimens is of utmost importance. The aim of this study was to describe the management, drug adverse effects and outcome of alternative combined treatment in a series of XDR-TB patients.es
dc.formatpdf-
dc.language.isoenes
dc.publisherOxford University Presses
dc.relation.ispartofThe Journal of antimicrobial chemotherapyes
dc.rightsOpen Access-
dc.sourceJournal of Antimicrobial Chemotherapy 2012; 67(2):473-7.-
dc.subjectTuberculosises
dc.subjectArgentinaes
dc.subjectLinezolides
dc.subjectMoxifloxacinoes
dc.subjectTioridazinaes
dc.titleSuccessful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazinees
dc.typeArtículoes
dc.identifier.doi10.1093/jac/dkr500-
anlis.essnrd1-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.grantfulltextopen-
item.openairetypeArtículo-
item.fulltextWith Fulltext-
item.languageiso639-1en-
Appears in Collections:Publicaciones INEI
Files in This Item:
File Description SizeFormat
10.1093_jac_dkr500.pdfArtículo en inglés156.67 kBAdobe PDFView/Open
Show simple item record

Page view(s)

20
checked on May 2, 2024

Download(s)

3
checked on May 2, 2024

Google ScholarTM

Check

Altmetric

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.